Search Results
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
negative impact on the quality of life of affected individuals ( 2 ) because of its disfiguring (exophthalmos) and dysfunctional (diplopia) features and can only partially be prevented by intervening to change modifiable risk factors ( 3 ). In the large
Search for other papers by Annamaria Erdei in
Google Scholar
PubMed
Search for other papers by Annamaria Gazdag in
Google Scholar
PubMed
Search for other papers by Bernadett Ujhelyi in
Google Scholar
PubMed
Search for other papers by Edit B Nagy in
Google Scholar
PubMed
Search for other papers by Ervin Berenyi in
Google Scholar
PubMed
Search for other papers by Eszter Berta in
Google Scholar
PubMed
Search for other papers by Zita Steiber in
Google Scholar
PubMed
Search for other papers by Sandor Barna in
Google Scholar
PubMed
Search for other papers by Emese Mezosi in
Google Scholar
PubMed
Search for other papers by Miklos Bodor in
Google Scholar
PubMed
Search for other papers by Endre V Nagy in
Google Scholar
PubMed
exophthalmos and symmetric periorbital edema were seen. Low thyroid-stimulating hormone (TSH) (0.006 mU/L, reference range: 0.3-4.2 mU/L) was accompanied by normal free thyroxine and free triiodothyronine levels and elevated TSH receptor antibodies (TRAb: 10
Search for other papers by Haitao Zhang in
Google Scholar
PubMed
Search for other papers by Hao Hu in
Google Scholar
PubMed
Search for other papers by Yueyue Wang in
Google Scholar
PubMed
Search for other papers by Xinjie Duan in
Google Scholar
PubMed
Search for other papers by Lu Chen in
Google Scholar
PubMed
Search for other papers by Jiang Zhou in
Google Scholar
PubMed
Search for other papers by Wen Chen in
Google Scholar
PubMed
Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Search for other papers by Weizhong Zhang in
Google Scholar
PubMed
Search for other papers by Xiaoquan Xu in
Google Scholar
PubMed
Search for other papers by Huanhuan Chen in
Google Scholar
PubMed
(including FT 3 , free thyroxine (FT 4 ), and thyroid-stimulating hormone) – were also collected and compared. Ophthalmic findings, including visual acuity, intraocular pressure, exophthalmos, eyelid width, the presence of diplopia, and binocular CAS, were
Search for other papers by Petros Perros in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
among experts, which generally included a ‘composite index’ among primary end points (improvement in at least two parameters such as palpebral aperture and exophthalmos, diplopia, CAS, and QOL) ( 26 ). A significant knowledge gap has therefore been
Department of Women’s and Children’s Health, Pediatric Endocrinology Unit, Padua University Hospital, Padua, Italy
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Cristina Clausi in
Google Scholar
PubMed
Search for other papers by Ilaria Piva in
Google Scholar
PubMed
Search for other papers by Yi Hang Zhu in
Google Scholar
PubMed
Search for other papers by Alberto Mondin in
Google Scholar
PubMed
Search for other papers by Maria Chiara Pedron in
Google Scholar
PubMed
Search for other papers by Susi Barollo in
Google Scholar
PubMed
Search for other papers by Loris Bertazza in
Google Scholar
PubMed
Search for other papers by Giulia Midena in
Google Scholar
PubMed
Search for other papers by Raffaele Parrozzani in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy . Clinical Science 1945 5 177 – 194 . 6 Werner SC . Modification of the classification of the eye changes of Graves' disease
Search for other papers by Michele Marinò in
Google Scholar
PubMed
Search for other papers by Giovanna Rotondo Dottore in
Google Scholar
PubMed
Search for other papers by Francesca Menconi in
Google Scholar
PubMed
Search for other papers by Simone Comi in
Google Scholar
PubMed
Search for other papers by Giada Cosentino in
Google Scholar
PubMed
Search for other papers by Roberto Rocchi in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Search for other papers by Michele Figus in
Google Scholar
PubMed
Search for other papers by Ferruccio Santini in
Google Scholar
PubMed
), especially hyaluronic acid (HA), by orbital fibroblasts ( 8 ). Features of GO include exophthalmos, eyelid edema or erythema, conjunctival redness and swelling, increased palpebral aperture, eye muscle enlargement with consequent diplopia, and in the most
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Endocrinology Division, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA
Search for other papers by Henry B Burch in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by David S Cooper in
Google Scholar
PubMed
Search for other papers by Peter J Dolman in
Google Scholar
PubMed
Search for other papers by Angela M Leung in
Google Scholar
PubMed
Search for other papers by Ilse Mombaerts in
Google Scholar
PubMed
Search for other papers by Mario Salvi in
Google Scholar
PubMed
Search for other papers by Marius N Stan in
Google Scholar
PubMed
-017-0625-1 ) 9 Rundle FF Management of exophthalmos and related ocular changes in Graves’ disease . Metabolism: Clinical and Experimental 1957 6 36 – 48 . 10 Taylor PN Zhang L Lee RWJ Muller I Ezra DG Dayan CM Kahaly GJ Ludgate M . New